Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Illumina: Teva Pharmaceutical Exclusive Distributor of Verifi Test in Israel

07/01/2013 | 07:27am US/Eastern
   By Melodie Warner 
 

Illumina Inc. (>> Illumina, Inc.) said Teva Pharmaceutical Industries Ltd. (>> Teva Pharmaceutical Industries Ltd (ADR)) will be the exclusive distributor of the verifi prenatal test in Israel under a five-year agreement.

Financial terms weren't disclosed.

Illumina paid $350 million in February to buy Verinata Health Inc., which gave it access to Verinata's verifi prenatal test, the broadest non-invasive prenatal test currently available for high-risk pregnancies.

The company said the MOR Institute for Medical Data Ltd., through its relationship with Teva, will provide the verifi test to customers of Clalit Health Services who are at high risk of having a fetus with a chromosomal abnormality.

The MOR Institute will also establish a 9,000-patient clinical outcomes registry to collect performance data and will share the data with Verinata.

Illumina said the patient registry developed through this collaboration will be the largest and most extensive of its kind.

Illumina shares closed Friday at $74.84 and were inactive premarket. The stock is up 35% this year.

Write to Melodie Warner at melodie.warner@dowjones.com

Stocks mentioned in the article : Illumina, Inc., Teva Pharmaceutical Industries Ltd (ADR)
React to this article
Latest news on TEVA PHARMACEUTICAL INDUST
02/04 TEVA PHARMACEUTICAL : to Report Fourth Quarter 2015 Financial Results on Februar..
02/03 TEVA PHARMACEUTICAL : Pharma Enters into Research Agreement with AbCellera Biolo..
02/02 TEVA PHARMACEUTICAL : teams with AbCellera on biologics
02/02 TEVA PHARMACEUTICAL : and AbCellera Enter Into Agreement to Discover Rare Monocl..
01/29 Charterhouse begins groundwork for $700 million-plus Doc Generici sale - sour..
01/28 TEVA PHARMACEUTICAL : and Eagle Pharmaceuticals Announce Commercial Availability..
01/28 TEVA PHARMACEUTICAL : Announces 2016 U.S. Community Partner Organizations
01/28 TEVA PHARMACEUTICAL : to Report Fourth Quarter 2015 Financial Results on Februar..
01/25 TEVA PHARMACEUTICAL : Releases Innovation and Social Responsibility Highlights
01/21 TEVA PHARMACEUTICAL : "Treatment of Multiple Sclerosis with Combination of Laqui..
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials